Dominik Berthold

10.7k total citations · 3 hit papers
102 papers, 5.9k citations indexed

About

Dominik Berthold is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Molecular Biology. According to data from OpenAlex, Dominik Berthold has authored 102 papers receiving a total of 5.9k indexed citations (citations by other indexed papers that have themselves been cited), including 49 papers in Pulmonary and Respiratory Medicine, 29 papers in Surgery and 26 papers in Molecular Biology. Recurrent topics in Dominik Berthold's work include Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Dominik Berthold is often cited by papers focused on Prostate Cancer Treatment and Research (32 papers), Prostate Cancer Diagnosis and Treatment (15 papers) and Bladder and Urothelial Cancer Treatments (15 papers). Dominik Berthold collaborates with scholars based in Switzerland, United States and France. Dominik Berthold's co-authors include Ǵerald Babcock, Charles F. Yocum, Gregory R. Pond, Ronald de Wit, Mario A. Eisenberger, Ian F. Tannock, Chad M. Rienstra, Pål Stenmark, P. Nordlund and Andrew J. Nieuwkoop and has published in prestigious journals such as The Lancet, Journal of the American Chemical Society and Journal of Biological Chemistry.

In The Last Decade

Dominik Berthold

100 papers receiving 5.7k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A highly resolved, oxygen‐evolving photosystem II preparation from spinach thylakoid membranes

1981 1.6k citations Dominik Berthold et al. profile →
Docetaxel Plus Prednisone or Mitoxantrone Plus Prednisone for Advanced Prostate Cancer: Updated Survival in the TAX 327 Study

2008 820 citations Dominik Berthold et al. profile →
Solid-state NMR structure of a pathogenic fibril of full-length human α-synuclein

2016 777 citations Dominik Berthold, Chad M. Rienstra et al. profile →

Peers

Countries citing papers authored by Dominik Berthold

Since Specialization

Citations

This map shows the geographic impact of Dominik Berthold's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dominik Berthold with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dominik Berthold more than expected).

Fields of papers citing papers by Dominik Berthold

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dominik Berthold. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dominik Berthold. The network helps show where Dominik Berthold may publish in the future.

Co-authorship network of co-authors of Dominik Berthold

This figure shows the co-authorship network connecting the top 25 collaborators of Dominik Berthold. A scholar is included among the top collaborators of Dominik Berthold based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dominik Berthold. Dominik Berthold is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Spatial Distribution of Recurrence and Long-Term Toxicity Following Dose Escalation to the Dominant Intra-Prostatic Nodule for Intermediate–High-Risk Prostate Cancer: Insights from a Phase I/II Study 2024 ·Cancers ·(unknown), (unknown), Sarah Boughdad, Niklaus Schaefer, John O. Prior, Michele Zeverino, Dominik Berthold, Thomas Tawadros, Jean‐Yves Meuwly, (unknown), (unknown), (unknown), F. Duclos, Véronique Vallet, Massimo Valério, Jean Bourhis, Fernanda Herrera	2
2	Efficacy and safety of prostate radiotherapy in de novo metastatic castration-sensitive prostate cancer (PEACE-1): a multicentre, open-label, randomised, phase 3 study with a 2 × 2 factorial design 2024 ·The Lancet ·Alberto Bossi, Stéphanie Foulon, Xavier Maldonado, Paul Sargos, (unknown), Paul Kelly, Aude Fléchon, Bertrand Tombal, S. Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacsó, Naji Salem, Fabio Calabrò, Jean-François Berdah, Ali Hasbini, Marlon Silva, Jihane Boustani, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	21
3	1361MO 8-month PSA strongly predicts outcomes of men with metastatic castration-sensitive prostate cancer in the PEACE-1 phase III trial 2022 ·Annals of Oncology ·Gwénaëlle Gravis, (unknown), Guilhem Roubaud, Ray McDermott, Aude Fléchon, Bertrand Tombal, S. Supiot, Dominik Berthold, (unknown), (unknown), Fabio Calabrò, Jean François Berdah, Ali Hasbini, (unknown), Antoine Thiery-Vuillemin, (unknown), John A. McCaffrey, (unknown), (unknown), Karim Fizazi	9
4	Overcoming Immune Resistance With Radiation Therapy in Prostate Cancer 2022 ·Frontiers in Immunology ·(unknown), (unknown), Dominik Berthold, Fernanda Herrera	12
5	Swiss germ-cell cancer consensus recommendations 2021 ·Swiss Medical Weekly ·J. Beyer, Dominik Berthold, (unknown), Richard Cathomas, Christian D. Fankhauser, Stefanie Fischer, Silke Gillessen, Tobias Gross, Thomas Hermanns, Friedemann Honecker, Anja Lorch, Aurelius Omlin, Alexandros Papachristofilou, Beat Roth, Christian Rothermundt, Roland Seiler, Martin Spahn, Frank Stenner, (unknown)	1
6	A new method to visualize and to spare the ureters during SBRT for oligo metastatic patients 2021 ·Technical Innovations & Patient Support in Radiation Oncology ·(unknown), Raphaël Moeckli, Véronique Vallet, Dominik Berthold, (unknown), Jean Bourhis, Fernanda Herrera	2
7	LBA5 A phase III trial with a 2x2 factorial design in men with de novo metastatic castration-sensitive prostate cancer: Overall survival with abiraterone acetate plus prednisone in PEACE-1 2021 ·Annals of Oncology ·Karim Fizazi, Joan Carles, (unknown), Guilhem Roubaud, Ray McDermott, Aude Fléchon, Bertrand Tombal, S. Supiot, Dominik Berthold, Philippe Ronchin, Gabriel Kacsó, Gwénaëlle Gravis, Fabio Calabrò, Jean François Berdah, Ali Hasbini, (unknown), Antoine Thiery-Vuillemin, I. Latorzeff, Isabelle Rieger, Alberto Bossi	31
8	716P Optimizing ipilimumab in metastatic renal cell carcinoma: SAKK 07/17 study 2020 ·Annals of Oncology ·Frank Stenner, Richard Cathomas, Christian Rothermundt, Julian Schardt, Anna Patrikidou, Deborah Zihler, Andreas Erdmann, (unknown), D. Dietrich, Catherine Berset, Gilles Godar, Dominik Berthold, Heinz Läubli	2
9	50-Gy Stereotactic Body Radiation Therapy to the Dominant Intraprostatic Nodule: Results From a Phase 1a/b Trial 2018 ·International Journal of Radiation OncologyBiologyPhysics ·Fernanda Herrera, Massimo Valério, Dominik Berthold, Thomas Tawadros, Jean‐Yves Meuwly, Véronique Vallet, Petra Baumgärtner, Anne‐Christine Thierry, Berardino De Bari, Patrice Jichlinski, Lana E. Kandalaft, George Coukos, Alexandre Harari, Jean Bourhis	33
10	Iterative Reconstructions in Reduced-Dose CT 2017 ·Academic Radiology ·(unknown), Kai Higashigaito, (unknown), Jean‐François Knebel, Dominik Berthold, Francis R. Verdun, Hatem Alkadhi, Sabine Schmidt	15
11	Site-Specific Protein Internal Motions Revealed by 2H Solid-State NMR Spectroscopy 2016 ·Biophysical Journal ·Xiangyan Shi, Dominik Berthold, Chad M. Rienstra	1
12	Successes and Limitations of Targeted Therapies in Renal Cell Carcinoma 2014 ·Progress in tumor research ·Marc Pracht, Dominik Berthold	6
13	[Immunotherapy: a therapeutic revolution against prostate cancer?]. 2013 ·PubMed ·Marc Pracht, Fernanda Herrera, Thomas Tawadros, Dominik Berthold	2
14	Secondary Cancer Risk for Stage I Seminoma Patients - a Comparison of Adjuvant Treatment Versus Surveillance 2011 ·IRIS ·Dominik Berthold, (unknown), (unknown), (unknown), Francis R. Verdun, Raphaël Moeckli, M. Ozsahin, Fernanda Herrera	1
15	[Active surveillance in prostate cancer]. 2011 ·PubMed ·Massimo Valério, (unknown), Yannick Cerantola, Dominik Berthold, Fabián Herrera, Patrice Jichlinski	4
16	Pharmacotherapeutic Management of Locally Advanced Prostate Cancer 2011 ·Drugs ·Jarad Martin, S. Supiot, Dominik Berthold	25
17	High-yield expression and purification of isotopically labeled cytochrome P450 monooxygenases for solid-state NMR spectroscopy 2007 ·Biochimica et Biophysica Acta (BBA) - Biomembranes ·Sanjeewa G. Rupasinghe, Hui Duan, Heather L. Frericks Schmidt, Dominik Berthold, Chad M. Rienstra, Mary A. Schuler	15
18	Treatment of malignant lymphoma 2004 ·Swiss Medical Weekly ·Dominik Berthold, Michele Ghielmini	8
19	Screening for functional expression and overexpression of a family of diiron‐containing interfacial membrane proteins using the univector recombination system 2003 ·Protein Science ·Dominik Berthold, Pål Stenmark, P. Nordlund	9
20	EPR Studies of the Mitochondrial Alternative Oxidase 2002 ·Journal of Biological Chemistry ·Dominik Berthold, Nina Voevodskaya, Pål Stenmark, Astrid Gräslund, P. Nordlund	64

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact